Patent ID: 7374753

Claim:
A method of reducing a bacterial gastrointestinal infection in a human, said bacterial gastrointestinal infection selected from the group consisting of Clostridium perfringens, Clostridium difficile, Clostridium botulinum, Clostridium tributrycum, Clostridium sporogenes, Escherichia coli, Pseudomonas aeruginosa , and Staphylococcus aureus , comprising the steps of: a) orally administering to a human subject in need thereof a composition comprising: i.) viable colony forming units (CFU) of a non-pathogenic lactic acid bacteria, wherein said non-pathogenic lactic acid bacteria is Bacillus coagulans ; and ii) an oral electrolyte maintenance formulation; and b) allowing said non-pathogenic lactic acid bacteria to grow in the human subject's gastrointestinal tract, thereby reducing a bacterial gastrointestinal infection.